메뉴 건너뛰기




Volumn 28, Issue 3, 2008, Pages 411-422

Pharmacogenomics: The Key to Improved Drug Therapy in Transplant Patients

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; CALCINEURIN INHIBITOR; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; CYTOCHROME P450 3A5; GLYCOPROTEIN P; GLYCOSYLTRANSFERASE; IMMUNOSUPPRESSIVE AGENT; INOSINATE DEHYDROGENASE; IRINOTECAN; MERCAPTOPURINE; METHYLPREDNISOLONE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; RAPAMYCIN; TACROLIMUS; THIOPURINE METHYLTRANSFERASE; UNCLASSIFIED DRUG; URIDINE GLYCOSYLTRANSFERASE; WARFARIN;

EID: 56349130877     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2008.09.004     Document Type: Review
Times cited : (8)

References (33)
  • 1
    • 38149127170 scopus 로고    scopus 로고
    • Qualification of biomarkers for drug development in organ transplantation
    • Burckart G.J., Amur S., Goodsaid F.M., et al. Qualification of biomarkers for drug development in organ transplantation. Am J Transplant 8 (2008) 267-270
    • (2008) Am J Transplant , vol.8 , pp. 267-270
    • Burckart, G.J.1    Amur, S.2    Goodsaid, F.M.3
  • 2
    • 34147176482 scopus 로고    scopus 로고
    • Cytochrome P4503A and TNF-α genotypes are associated with tacrolimus dosing in pediatric heart transplant patients
    • Zheng H., Webber S., Schuetz E., et al. Cytochrome P4503A and TNF-α genotypes are associated with tacrolimus dosing in pediatric heart transplant patients. Hum Immunol 63 Suppl 1 (2002) S15
    • (2002) Hum Immunol , vol.63 , Issue.SUPPL. 1
    • Zheng, H.1    Webber, S.2    Schuetz, E.3
  • 3
    • 16544365185 scopus 로고    scopus 로고
    • Genetics of the variable expression of CYP3A in humans
    • Wojnowski L. Genetics of the variable expression of CYP3A in humans. Ther Drug Monit 26 (2004) 192-199
    • (2004) Ther Drug Monit , vol.26 , pp. 192-199
    • Wojnowski, L.1
  • 4
    • 33845917818 scopus 로고    scopus 로고
    • Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients
    • Girnita D.M., Webber S.A., Ferrell R., et al. Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients. Transplantation 82 (2006) 1774-1780
    • (2006) Transplantation , vol.82 , pp. 1774-1780
    • Girnita, D.M.1    Webber, S.A.2    Ferrell, R.3
  • 5
    • 11144358432 scopus 로고    scopus 로고
    • CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation
    • Anglicheau D., Thervet E., Etienne I., et al. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin Pharmacol Ther 75 (2004) 422-433
    • (2004) Clin Pharmacol Ther , vol.75 , pp. 422-433
    • Anglicheau, D.1    Thervet, E.2    Etienne, I.3
  • 6
    • 9144245517 scopus 로고    scopus 로고
    • Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism
    • Zheng H., Zeevi A., Schuetz E., et al. Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism. J Clin Pharmacol 44 (2004) 135-140
    • (2004) J Clin Pharmacol , vol.44 , pp. 135-140
    • Zheng, H.1    Zeevi, A.2    Schuetz, E.3
  • 7
    • 31044454408 scopus 로고    scopus 로고
    • Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation
    • Yu S., Wu L., Jin J., et al. Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation. Transplantation 81 (2006) 46-51
    • (2006) Transplantation , vol.81 , pp. 46-51
    • Yu, S.1    Wu, L.2    Jin, J.3
  • 8
    • 33646439263 scopus 로고    scopus 로고
    • Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients
    • Wei-lin W., Jing J., Shu-sen Z., et al. Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients. Liver Transpl 12 (2006) 775-780
    • (2006) Liver Transpl , vol.12 , pp. 775-780
    • Wei-lin, W.1    Jing, J.2    Shu-sen, Z.3
  • 9
    • 33749984168 scopus 로고    scopus 로고
    • CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study
    • Haufroid V., Wallemacq P., VanKerckhove V., et al. CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. Am J Transplant 6 (2006) 2706-2713
    • (2006) Am J Transplant , vol.6 , pp. 2706-2713
    • Haufroid, V.1    Wallemacq, P.2    VanKerckhove, V.3
  • 10
    • 34447549311 scopus 로고    scopus 로고
    • Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms
    • Op den Buijsch R.A., Christiaans M.H., Stolk L.M., et al. Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms. Fundam Clin Pharmacol 21 (2007) 427-435
    • (2007) Fundam Clin Pharmacol , vol.21 , pp. 427-435
    • Op den Buijsch, R.A.1    Christiaans, M.H.2    Stolk, L.M.3
  • 11
    • 34548628553 scopus 로고    scopus 로고
    • Pharmacogenetics as a tool for optimising drug therapy in solid organ transplantation
    • Ng F.L., Holt D.W., and MacPhee I.A. Pharmacogenetics as a tool for optimising drug therapy in solid organ transplantation. Expert Opin Pharmacother 8 (2007) 2045-2058
    • (2007) Expert Opin Pharmacother , vol.8 , pp. 2045-2058
    • Ng, F.L.1    Holt, D.W.2    MacPhee, I.A.3
  • 12
    • 36148985704 scopus 로고    scopus 로고
    • CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients
    • Kuypers D.R., de Jonge H., Naesens M., et al. CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients. Clin Pharmacol Ther 82 (2007) 711-725
    • (2007) Clin Pharmacol Ther , vol.82 , pp. 711-725
    • Kuypers, D.R.1    de Jonge, H.2    Naesens, M.3
  • 13
    • 34548676182 scopus 로고    scopus 로고
    • Pharmacogenetics of tacrolimus and sirolimus in renal transplant patients: from retrospective analyses to prospective studies
    • Anglicheau D., Legendre C., and Thervet E. Pharmacogenetics of tacrolimus and sirolimus in renal transplant patients: from retrospective analyses to prospective studies. Transplant Proc 39 (2007) 2142-2144
    • (2007) Transplant Proc , vol.39 , pp. 2142-2144
    • Anglicheau, D.1    Legendre, C.2    Thervet, E.3
  • 14
    • 33745344584 scopus 로고    scopus 로고
    • CYP3A5*3 influences sirolimus oral clearance in de novo and stable renal transplant recipients
    • Le Meur Y., Djebli N., Szelag J.C., et al. CYP3A5*3 influences sirolimus oral clearance in de novo and stable renal transplant recipients. Clin Pharmacol Ther 80 (2006) 51-60
    • (2006) Clin Pharmacol Ther , vol.80 , pp. 51-60
    • Le Meur, Y.1    Djebli, N.2    Szelag, J.C.3
  • 15
    • 33645804424 scopus 로고    scopus 로고
    • Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition
    • Lee S.J., Jusko W.J., Salaita C.G., et al. Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition. J Clin Pharmacol 46 (2006) 515-526
    • (2006) J Clin Pharmacol , vol.46 , pp. 515-526
    • Lee, S.J.1    Jusko, W.J.2    Salaita, C.G.3
  • 16
    • 34147109227 scopus 로고    scopus 로고
    • Influence of the CYP3A5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients [see comment]
    • Ferraresso M., Tirelli A., Ghio L., et al. Influence of the CYP3A5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients [see comment]. Pediatr Transplant 11 (2007) 296-300
    • (2007) Pediatr Transplant , vol.11 , pp. 296-300
    • Ferraresso, M.1    Tirelli, A.2    Ghio, L.3
  • 17
    • 0037693831 scopus 로고    scopus 로고
    • Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms
    • Zheng H., Webber S., Zeevi A., et al. Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. Am J Transplant 3 (2003) 477-483
    • (2003) Am J Transplant , vol.3 , pp. 477-483
    • Zheng, H.1    Webber, S.2    Zeevi, A.3
  • 18
    • 34648857526 scopus 로고    scopus 로고
    • 1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation
    • Elens L., Capron A., Kerckhove V.V., et al. 1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation. Pharmacogenet Genomics 17 (2007) 873-883
    • (2007) Pharmacogenet Genomics , vol.17 , pp. 873-883
    • Elens, L.1    Capron, A.2    Kerckhove, V.V.3
  • 19
    • 38149024948 scopus 로고    scopus 로고
    • Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms
    • Fanta S., Niemi M., Jonsson S., et al. Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms. Pharmacogenet Genomics 18 (2008) 77-90
    • (2008) Pharmacogenet Genomics , vol.18 , pp. 77-90
    • Fanta, S.1    Niemi, M.2    Jonsson, S.3
  • 20
    • 21444449731 scopus 로고    scopus 로고
    • ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation
    • Hauser I.A., Schaeffeler E., Gauer S., et al. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation. J Am Soc Nephrol 16 (2005) 1501-1511
    • (2005) J Am Soc Nephrol , vol.16 , pp. 1501-1511
    • Hauser, I.A.1    Schaeffeler, E.2    Gauer, S.3
  • 21
    • 0036729669 scopus 로고    scopus 로고
    • The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients
    • Zheng H., Webber S., Zeevi A., et al. The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients. Hum Immunol 63 (2002) 765-770
    • (2002) Hum Immunol , vol.63 , pp. 765-770
    • Zheng, H.1    Webber, S.2    Zeevi, A.3
  • 22
    • 11144223846 scopus 로고    scopus 로고
    • The impact of pharmacogenomic factors on steroid dependency in pediatric heart transplant patients using logistic regression analysis
    • Zheng H.X., Webber S.A., Zeevi A., et al. The impact of pharmacogenomic factors on steroid dependency in pediatric heart transplant patients using logistic regression analysis. Pediatr Transplant 8 (2004) 551-557
    • (2004) Pediatr Transplant , vol.8 , pp. 551-557
    • Zheng, H.X.1    Webber, S.A.2    Zeevi, A.3
  • 23
    • 48149098366 scopus 로고    scopus 로고
    • The impact of P-glycoprotein and Mrp2 on mycophenolic acid levels in mice
    • Wang J., Figurski M., Shaw L.M., et al. The impact of P-glycoprotein and Mrp2 on mycophenolic acid levels in mice. Transpl Immunol 19 (2008) 192-196
    • (2008) Transpl Immunol , vol.19 , pp. 192-196
    • Wang, J.1    Figurski, M.2    Shaw, L.M.3
  • 24
    • 33750346955 scopus 로고    scopus 로고
    • Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients
    • Naesens M., Kuypers D.R., Verbeke K., et al. Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients. Transplantation 82 (2006) 1074-1084
    • (2006) Transplantation , vol.82 , pp. 1074-1084
    • Naesens, M.1    Kuypers, D.R.2    Verbeke, K.3
  • 25
    • 50549089562 scopus 로고    scopus 로고
    • Impact of inosine 5′-monophosphate dehyrogenase 1,2 and multidrug resistance protein 2 genetic polymorphisms on mycophenolate mofetil-related adverse events in pediatric heart transplant patients
    • Ohmann E.L., Burckart G.J., Chen Y., et al. Impact of inosine 5′-monophosphate dehyrogenase 1,2 and multidrug resistance protein 2 genetic polymorphisms on mycophenolate mofetil-related adverse events in pediatric heart transplant patients. J Heart Lung Transplant 27 (2008) S181
    • (2008) J Heart Lung Transplant , vol.27
    • Ohmann, E.L.1    Burckart, G.J.2    Chen, Y.3
  • 26
    • 36148991372 scopus 로고    scopus 로고
    • Influence of SLCO1B1, 1B3, 2B1, and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients
    • Miura M., Satoh S., Inoue K., et al. Influence of SLCO1B1, 1B3, 2B1, and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. Eur J Clin Pharmacol 63 (2007) 1161-1169
    • (2007) Eur J Clin Pharmacol , vol.63 , pp. 1161-1169
    • Miura, M.1    Satoh, S.2    Inoue, K.3
  • 27
    • 45849107951 scopus 로고    scopus 로고
    • Clinical pharmacology and pharmacogenetics of thiopurines
    • Sahasranaman S., Howard D., Roy S., et al. Clinical pharmacology and pharmacogenetics of thiopurines. Eur J Clin Pharmacol 64 (2008) 753-767
    • (2008) Eur J Clin Pharmacol , vol.64 , pp. 753-767
    • Sahasranaman, S.1    Howard, D.2    Roy, S.3
  • 28
    • 42049122605 scopus 로고    scopus 로고
    • Role of pharmacogenetics of immunosuppressive drugs in organ transplantation
    • Thervet E., Anglicheau D., Legendre C., et al. Role of pharmacogenetics of immunosuppressive drugs in organ transplantation. Ther Drug Monit 30 (2008) 143-150
    • (2008) Ther Drug Monit , vol.30 , pp. 143-150
    • Thervet, E.1    Anglicheau, D.2    Legendre, C.3
  • 29
    • 47249151375 scopus 로고    scopus 로고
    • Pharmacogenetics of immunosuppressants: progress, pitfalls, and promises
    • Cattaneo D., Baldelli S., and Perico N. Pharmacogenetics of immunosuppressants: progress, pitfalls, and promises. Am J Transplant 8 (2008) 1374-1383
    • (2008) Am J Transplant , vol.8 , pp. 1374-1383
    • Cattaneo, D.1    Baldelli, S.2    Perico, N.3
  • 30
    • 34247614888 scopus 로고    scopus 로고
    • A novel variant L263F in human inosine 5′-monophosphate dehydrogenase 2 is associated with diminished enzyme activity
    • Wang J., Zeevi A., Webber S., et al. A novel variant L263F in human inosine 5′-monophosphate dehydrogenase 2 is associated with diminished enzyme activity. Pharmacogenet Genomics 17 (2007) 283-290
    • (2007) Pharmacogenet Genomics , vol.17 , pp. 283-290
    • Wang, J.1    Zeevi, A.2    Webber, S.3
  • 31
    • 42349115968 scopus 로고    scopus 로고
    • IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients
    • Wang J., Yang J.W., Zeevi A., et al. IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients. Clin Pharmacol Ther 83 (2008) 711-717
    • (2008) Clin Pharmacol Ther , vol.83 , pp. 711-717
    • Wang, J.1    Yang, J.W.2    Zeevi, A.3
  • 32
    • 56349149401 scopus 로고    scopus 로고
    • Progress in the direct application of pharmacogenomics to patient care: sustaining innovation
    • Burckart G.J., Frueh F.W., and Lesko L.J. Progress in the direct application of pharmacogenomics to patient care: sustaining innovation. J Appl Pharmacol 15 (2007) 1-6
    • (2007) J Appl Pharmacol , vol.15 , pp. 1-6
    • Burckart, G.J.1    Frueh, F.W.2    Lesko, L.J.3
  • 33
    • 56349121045 scopus 로고    scopus 로고
    • Dosage calculation algorithm. Available at: http://www.warfarindosing.org. Barnes-Jewish Hospital at Washington University Medical Center. Accessed November 2, 2008.
    • Dosage calculation algorithm. Available at: http://www.warfarindosing.org. Barnes-Jewish Hospital at Washington University Medical Center. Accessed November 2, 2008.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.